Linkage Assurance Plc (NGX:LINKASSURE)

CTI BioPharma Balance Sheet

Financials in millions NGN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Investments in Debt Securities	-	2,575	1,842	802.78	150	881.59
Investments in Equity & Preferred Securities	-	26,915	19,474	16,116	18,552	14,903
Policy Loans	-	13.66	13.66	13.66	-	-
Other Investments	51,423	16,039	12,067	6,215	3,690	9,038
Total Investments	51,763	47,986	36,059	26,156	27,600	25,217
Cash & Equivalents	4,448	5,417	5,507	4,188	3,477	3,593
Reinsurance Recoverable	6,484	5,571	4,025	4,903	3,839	1,593
Other Receivables	3,112	2,106	1,081	898.81	245.87	208.46
Deferred Policy Acquisition Cost	-	-	-	-	432.83	328.81
Property, Plant & Equipment	3,342	3,434	3,466	1,606	1,492	1,350
Other Intangible Assets	29.49	33.91	33.1	20.84	36.87	1.2
Restricted Cash	770	700	700	700	500	300
Other Current Assets	-	429.59	456.65	316.51	1,087	1,286
Other Long-Term Assets	-	-	0	-	-	-
Total Assets	69,949	65,677	51,327	38,790	38,710	33,877
Accrued Expenses	102.33	2,630	2,209	779.22	480.81	602.76
Insurance & Annuity Liabilities	21,544	17,387	5,316	3,620	0.98	0.98
Unpaid Claims	-	-	10,024	9,572	8,869	3,669
Unearned Premiums	-	22.37	35.53	21.71	2,987	2,237
Reinsurance Payable	-	102.54	129.86	595.73	481.53	504.93
Current Portion of Leases	-	-	-	-	-	0.22
Current Income Taxes Payable	113.65	245.56	174.59	157.85	60.26	82.57
Long-Term Deferred Tax Liabilities	2,037	2,037	-	-	-	-
Other Current Liabilities	832.07	65.51	61.95	24.93	635.32	340.32
Other Long-Term Liabilities	632.46	343	343	343	-	-
Total Liabilities	25,261	22,832	18,295	15,199	13,604	7,502
Common Stock	7,700	7,700	7,000	7,000	7,000	5,000
Additional Paid-In Capital	547.43	547.43	560.29	560.29	560.29	729.04
Retained Earnings	11,909	10,121	5,969	687.71	-634.68	5,856
Comprehensive Income & Other	24,531	24,476	19,503	15,344	18,180	14,791
Shareholders' Equity	44,688	42,845	33,032	23,592	25,106	26,376
Total Liabilities & Equity	69,949	65,677	51,327	38,790	38,710	33,877
Filing Date Shares Outstanding	15,296	18,480	18,480	18,480	18,480	18,480
Total Common Shares Outstanding	15,296	18,480	18,480	18,480	18,480	18,480
Total Debt	-	-	-	-	-	0.22
Net Cash (Debt)	4,448	5,417	5,507	4,188	3,477	3,592
Net Cash Growth	-18.61%	-1.65%	31.49%	20.47%	-3.22%	132.18%
Net Cash Per Share	0.26	0.29	0.30	0.23	0.19	0.19
Book Value Per Share	2.92	2.32	1.79	1.28	1.36	1.43
Tangible Book Value	44,658	42,811	32,999	23,571	25,069	26,375
Tangible Book Value Per Share	2.92	2.32	1.79	1.28	1.36	1.43
Land	-	1,439	1,439	847.42	847.42	847.42
Buildings	-	926.12	581.18	287.82	287.82	287.82
Machinery	-	2,611	2,477	1,495	1,248	1,112
Construction In Progress	-	92.17	275.88	85.86	85.86	85.86

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.